Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Tobacco Use Disorder, Colorectal Neoplasms

NCT03197389 2021-05-19

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Phase EARLY_PHASE1 Completed

54 enrolled 9 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03661892 2021-04-29

Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets

Phase EARLY_PHASE1 Completed

14 enrolled

Breast

Breast Neoplasms, Pain

NCT02590458 2020-12-01

Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer

Phase EARLY_PHASE1 Completed

131 enrolled

Breast

Breast Neoplasms

NCT01875666 2020-09-04

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

Phase EARLY_PHASE1 Completed

26 enrolled

Breast

Breast Neoplasms

NCT01467310 2020-09-02

Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212

Phase EARLY_PHASE1 Completed

15 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00949247 2020-07-27

Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases

Phase EARLY_PHASE1 Completed

20 enrolled

Breast

Breast Neoplasms

NCT02352025 2020-07-22

S-equol in Women With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Completed

39 enrolled

Breast

Breast Neoplasms

NCT01823991 2020-07-14

COGNUTRIN in Breast Cancer Survivors

Phase EARLY_PHASE1 Completed

36 enrolled 15 charts

Breast

Breast Neoplasms

NCT00510367 2020-07-10

Primary Breast Cancer Occurring Concomitant With Pregnancy

Phase EARLY_PHASE1 Completed

61 enrolled

Breast

Breast Neoplasms

NCT02802098 2020-06-19

Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer

Phase EARLY_PHASE1 Completed

25 enrolled

Breast

Breast Neoplasms

NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Phase EARLY_PHASE1 Completed

3 enrolled 6 charts

BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

NCT00331630 2020-03-06

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Phase EARLY_PHASE1 Completed

30 enrolled 13 charts

Breast

Breast Neoplasms

Clinical Trials

Window of Opportunity Study Targeting the Inflammatory Milieu

Mirtazapine for Acute and Chronic Post Mastectomy Pain

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

PROMETEO

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

ICG and SLN Mapping

HPCardiotox

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

Pediatric Reporting of Adult-Onset Genomic Results

RANKL Inhibition and Breast Tissue Biomarkers

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

CARSPECT

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

IMPACT

64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

3D Ultrasound Microvessel Imaging for Breast Masses

Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Omega-3 and Vitamin D Supplementation in Breast Cancer Women

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

Examining Bioactivity of PVSRIPO in Invasive Breast Cancer

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2

Digoxin Induced Dissolution of CTC Clusters

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Side-Out

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

Imipramine on ER+ve and Triple Negative Breast Cancer

HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

ELIPSE

RELIEF

Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to Chemotherapy

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets

Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212

Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases

S-equol in Women With Triple Negative Breast Cancer

COGNUTRIN in Breast Cancer Survivors

Primary Breast Cancer Occurring Concomitant With Pregnancy

Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer